View Older Stories View More Recent Stories
-
OSI Pharma (OSIP) Rejects Astellas' $52/Share Cash Acquistion Bid
-
Baltic Trading (BALT) IPO Trades Flat
-
Baltic Trading Ltd (BALT) IPO Prices at $14, Low End of Range
-
Goldman Sachs Added Evercore Partners (EVR) to their Conviction Buy List, Removes Lazard (LAZ)
-
Sauer-Danfoss (SHS) Board Confirms $13.25/Share Tender Offer for Outstanding Common
-
Lazard Upgrades Fifth Street (FSC), Pennant (PNNT) to Buy
-
Lazard Capital Markets Lifts Price Target on Dendreon (DNDN) to $39
-
Lazard Capital Upgrades Allergan (AGN) to Buy
-
Analyst Doubles Price Target On TiVo (TIVO) After Positive Court Ruling
-
Baltic Trading (BALT) Sees IPO Price of $14-$16
-
Notable Analyst Rating Changes 03/02: DELL, MRVL, SNDK, SQNM Upgraded; KMB, NUHC, OSIP, PALM Downgraded
-
Lazard Capital Upgrades Marvell Technology (MRVL) to Buy
-
Nexsan (NXSN) Sees IPO Price of $10-$12
-
Baltic Trading (BALT) Files $299.92M IPO
-
Baltic Trading (BALT) Files 16.3M IPO; Sees Price of $14 - $16/Share (GNK)
-
Comcast (CMCSA)(CMCSK) Promotes William Dordelman to SVP and Treasurer
-
Q4 Results Strong, Analysts Mixed; Traders Just Shrug and Sell Shares of XenoPort (XNPT)
-
Discovery Labs (DSCO) Completes 27.5M Common Offering; Reports Net Proceeds of $15.1M
-
Capstone Turbine (CPST) Prices ~38.1M Shares at $1.05/Share for Gross Proceeds of $40M
-
Capstone Turbine Corp. (CPST) Announces Common Offering; Quantity Not Specified
-
Parade of Analysts Downgrade XenoPort (XNPT) Following FDA Response Letter on Horizant
-
Notable Analyst Rating Changes 02/18: BEAT, CRM, FSLR, NUE Upgrades; XNPT, CSCX, NTAP, THOR Downgraded
-
Ladenburg Thalmann & Lazard Capital Downgrade Xenoport (XNPT) to Sell
-
Lazard Capital Downgrades Thoratec (THOR) to Sell
-
Vermillion (VRML) Elects Peter Roddy to Board; Provides Corporate Update
-
Discovery Laboratories (DSCO) Plans Stock and Warrant Offering
-
Lazard Capital & Thomas Weisel Initiate Coverage on Art Technology Group (ARTG)
-
Lazard Capital Initiates Coverage on Aixtron AG (AIXG) with a Buy
-
Notable Analyst rating Changes for 02/05: RMD, WFR, ALKS, SFN, BEBE Upgraded; FWD, EGOV, LEAP, COH, CIEN Downgraded
-
Lazard Capital Initiates Coverage on Veeco Instruments (VECO) with a Buy
-
Lazard (LAZ) Posts Q4 Loss of $0.46, Narrower than Expected
-
Trading Radar for 02/03: Cisco (CSCO), ON Semi (ONNN), Visa (V), Novellus (NVLS), Monster Worldwide (MWW) Report
-
Talbots (TLB) Sinks Mid-Day as Lazard Cuts to Hold
-
Lazard Capital Maintains a 'Buy' on MAP Pharmaceuticals (MAPP); Raises Price Target
-
Lazard Capital Upgrades Anadarko Petroleum (APC) to Buy
-
Daqo New Energy (DQ) Lowers IPO Price from $12.50-$14.50 to $10-$11
-
BlackRock (BLK) Announces New Vice Chair, Kendrick Wilson
-
Unusual 11 Mid-Day Movers 1/28: NFLX, PFBC, NLST, EK Higher; KSP, AMRN, CNLG, TTEK Lower
-
Notable Analyst Rating Change of the Day 01/28: NFLX, STI, ZION, CMA, FITB, CAT Upgraded; TTEK, ME, KEX, QCOM Downgraded
-
Morning Movers 1/28: PFBC, NFLX, ESIO, MEG, EK, ETRM Higher; KSP, TTEK, QCOM, CTS, LSI Lower
-
Lazard (LAZ) Declares $0.125 Quarterly Dividend; 1.3% Yield
-
Lazard Capital Markets Upgrades Netflix, Inc. (NFLX) to Hold
-
Lazard Capital Markets upgrades Global Payments (GPN) to Buy
-
Lazard Capital Initiates Coverage on ShoreTel (SHOR) with a Buy
-
Sirius (SIRI) Shares Rising as Wunderlich Starts at Buy, Sets $1 Price Target
-
Lazard's (LAZ) Rohatyn Returns to Company as Special Adviser to Chairman
-
Notable Analyst Rating Changes 01/26: AMLN, PVTB, VLTR, AMAT, SPWRA, NVLS Upgraded; CI, WBD, JCI, GXDX Downgraded
-
Lazard Capital Initiates Coverage on Liberty Media Stocks
-
Lazard Capital and Argus Downgrade St. Jude Medical (STJ) to Hold
-
Daily State of the Markets 1/26: Lackluster At Best

